胡哲銘博士
長聘副研究員
- 2652-3089 (Lab) (Room No: N534)
- 2788-7641 (Fax)
-
Specialty:
Biomaterials and Nanotechnology for Drug and Vaccine Development
Education and Positions:
B.S. University of California, Berkeley (Biomedical Engineering)
Ph.D. University of California, San Diego (Bioengineering)
奈米科技於生物醫學上的應用可強化及改善現有的藥物及疫苗製劑，以達到更高的效能和安全性。在藥物輸導及疫苗研發上，奈米粒子都具有極大的影響, 對於藥動學以及免疫激活的調整皆有很大的價值。本實驗室的研究重點以臨床技轉為重心開發創新的醫療材料。通過探討生物材料與生物組織間的作用，來設計與研發新型的奈米製劑以作為疾病的治療，包括心血管疾病，癌症和傳染病等。
Our Team
期刊 72
專書 0
期刊 72 專書 0
- Liu Cheng-Hao, Pan Yi-Chung, Lim See-Khai, Mou Chung-Yuan, 「Hu Che-Ming Jack*」, Mou Kurt Yun Combinatorial leaky probiotic for anticancer immunopotentiation and tumor eradication. Cell Reports Medicine 5(11), 101793 (2024-11) [JCR] [WOS]
- Lin Chi-Long, Fang Zih-Syun, Hsu Chung-Yao, Liu Yu-Han, Lin Jung-Chen, Yao Bing-Yu, Li Fu-An, Yen Shin-Chwen Bruce, Chang Yuan-Chih,「Hu Che-Ming J*」 Rapid plasma membrane isolation via intracellular polymerization-mediated biomolecular confinement. Acta Biomaterialia 173, 325-335 (2024-01-01) [JCR] [WOS]
- Lim S-K, Lin W-C, Huang S-W, Pan Y-C, Hu C-W, Mou C-Y, 「Hu C-M*」, Mou K Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy. EMBO MOLECULAR MEDICINE (2024) [JCR] [WOS]
- Chiu CT, Tsai HH, Chen JY, 「Hu CJ」, Chen HW* An Immunoreceptor-Targeting Strategy with Minimalistic C3b Peptide Fusion Enhances SARS-CoV-2 RBD mRNA Vaccine Immunogenicity.. International journal of nanomedicine 19, 7201-7214 (2024) [JCR] [WOS]
- Wu J, Roesger S, Jones N, 「Hu CJ」, Li SD* Cell-penetrating peptides for transmucosal delivery of proteins.. Journal of controlled release : official journal of the Controlled Release Society 366, 864-878 (2024) [JCR] [WOS]
- Baghdasaryan O, Contreras-Llano LE, Khan S, Wang A, 「Hu CJ*」, Tan C* Fabrication of cyborg bacterial cells as living cell-material hybrids using intracellular hydrogelation.. Nature protocols 19(12), 3613-3639 (2024) [JCR] [WOS]
- Yu YA, Lien WJ, Lin WC, Pan YC, Huang SW, Mou CY, 「Hu CJ*」, Mou KY High-Affinity Superantigen-Based Trifunctional Immune Cell Engager Synergizes NK and T Cell Activation for Tumor Suppression.. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11(33), e2310204 (2024) [JCR] [WOS]
- Huang SW, Lim SK, Yu YA, Pan YC, Lien WJ, Mou CY*, 「 Hu CJ*」, Mou KY Overcoming the nutritional immunity by engineering iron-scavenging bacteria for cancer therapy.. eLife 12, RP90798 (2024) [JCR] [WOS]
- Baghdasaryan Ofelya, Khan Shahid, Lin Jung-Chen, Lee-Kin Jared, Hsu Chung-Yao, 「Hu Che-Ming Jack*」, Tan Cheemeng* Synthetic control of living cells by intracellular polymerization. Trends in Biotechnology (2023-09-01) [JCR] [WOS]
- Francisco Jamie, Guan Jin, Zhang Yu, Nakada Yasuki, Mareedu Satvik, Sung Eun-Ah, 「Hu Che-Ming」, Oka Shinichi, Zhai Peiyong, Sadoshima Junichi, Del Re Dominic P*. Suppression of myeloid YAP antagonizes adverse cardiac remodeling during pressure overload stress. Journal of Molecular and Cellular Cardiology 181, 1-14 (2023-08-01) [JCR] [WOS]
2019 Excellent Young Investigator Award—Taiwan Biomaterials and Controlled Releases Society
2017 Futuristic Breakthrough Technology Award by Ministry of Science and Technology.
2016 4th Annual Excellence in Creativity Award for Young Scholar
2016 Member of the Global Young Academy
2016 Recipient of the Academia Sinica Career Development Award
2014 Selected participant of the 64th Meeting of Nobel Laureates
2013 Chancellor’s Postdoctoral Scholar Award, UCSD 2013
2011 Siebel Scholar, Class of 2012
2010 Best poster award at the 8th NanoDDS
2004 Guidant Undergraduate Research Fellowship